SK13892003A3 - Spôsob autológnej transplantácie - Google Patents

Spôsob autológnej transplantácie Download PDF

Info

Publication number: SK13892003A3
Authority: SK; Slovakia
Prior art keywords: cells; cartilage; membrane; collagen; support
Prior art date: 2001-04-12

Application number

SK1389-2003A

Other languages

English (en)

Slovak (sk)

Inventor

Bruno M. Giannetti

Samuel S. Asculai

Ahmed Idouraine

Original Assignee

Verigen Transplantation Service International (Vtsi) Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-12

Filing date

2002-04-12

Publication date

2004-07-07

2002-04-12 Application filed by Verigen Transplantation Service International (Vtsi) Ag filed Critical Verigen Transplantation Service International (Vtsi) Ag

2004-07-07 Publication of SK13892003A3 publication Critical patent/SK13892003A3/sk

Links

238000000034 method Methods 0.000 title description 38
238000002054 transplantation Methods 0.000 title description 14
210000001612 chondrocyte Anatomy 0.000 claims abstract description 123
210000004027 cell Anatomy 0.000 claims abstract description 111
210000000845 cartilage Anatomy 0.000 claims description 101
239000012528 membrane Substances 0.000 claims description 78
102000008186 Collagen Human genes 0.000 claims description 72
108010035532 Collagen Proteins 0.000 claims description 72
229920001436 collagen Polymers 0.000 claims description 72
239000000853 adhesive Substances 0.000 claims description 28
210000001519 tissue Anatomy 0.000 claims description 26
230000001070 adhesive effect Effects 0.000 claims description 25
230000007547 defect Effects 0.000 claims description 21
206010061762 Chondropathy Diseases 0.000 claims description 11
102000012422 Collagen Type I Human genes 0.000 claims description 6
108010022452 Collagen Type I Proteins 0.000 claims description 6
210000001188 articular cartilage Anatomy 0.000 claims description 3
102000001187 Collagen Type III Human genes 0.000 claims description 2
108010069502 Collagen Type III Proteins 0.000 claims description 2
229940096422 collagen type i Drugs 0.000 claims description 2
230000000968 intestinal effect Effects 0.000 claims description 2
238000002513 implantation Methods 0.000 abstract description 18
230000035876 healing Effects 0.000 abstract description 2
210000000936 intestine Anatomy 0.000 abstract description 2
230000008929 regeneration Effects 0.000 abstract 1
238000011069 regeneration method Methods 0.000 abstract 1
239000000243 solution Substances 0.000 description 75
210000004379 membrane Anatomy 0.000 description 68
235000010633 broth Nutrition 0.000 description 56
239000007943 implant Substances 0.000 description 56
230000004888 barrier function Effects 0.000 description 42
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 37
230000002439 hemostatic effect Effects 0.000 description 32
239000010410 layer Substances 0.000 description 32
239000000463 material Substances 0.000 description 31
235000015097 nutrients Nutrition 0.000 description 27
239000002609 medium Substances 0.000 description 23
229940033618 tisseel Drugs 0.000 description 23
108010009565 Bio-Gide Proteins 0.000 description 20
210000002966 serum Anatomy 0.000 description 19
230000006378 damage Effects 0.000 description 15
230000012010 growth Effects 0.000 description 15
239000000047 product Substances 0.000 description 15
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 14
210000000988 bone and bone Anatomy 0.000 description 14
230000008439 repair process Effects 0.000 description 13
230000035899 viability Effects 0.000 description 13
238000001574 biopsy Methods 0.000 description 12
239000000203 mixture Substances 0.000 description 12
239000002253 acid Substances 0.000 description 11
108090000631 Trypsin Proteins 0.000 description 10
102000004142 Trypsin Human genes 0.000 description 10
229940030225 antihemorrhagics Drugs 0.000 description 10
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
208000035475 disorder Diseases 0.000 description 10
239000001963 growth medium Substances 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
230000002792 vascular Effects 0.000 description 10
102000000503 Collagen Type II Human genes 0.000 description 9
108010041390 Collagen Type II Proteins 0.000 description 9
208000027418 Wounds and injury Diseases 0.000 description 9
239000000306 component Substances 0.000 description 9
230000000025 haemostatic effect Effects 0.000 description 9
238000011534 incubation Methods 0.000 description 9
208000014674 injury Diseases 0.000 description 9
239000012588 trypsin Substances 0.000 description 9
102000016942 Elastin Human genes 0.000 description 8
108010014258 Elastin Proteins 0.000 description 8
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 8
208000015100 cartilage disease Diseases 0.000 description 8
239000003795 chemical substances by application Substances 0.000 description 8
229920002549 elastin Polymers 0.000 description 8
238000003780 insertion Methods 0.000 description 8
230000037431 insertion Effects 0.000 description 8
238000010186 staining Methods 0.000 description 8
239000000126 substance Substances 0.000 description 8
241000283690 Bos taurus Species 0.000 description 7
238000004113 cell culture Methods 0.000 description 7
230000008569 process Effects 0.000 description 7
238000011282 treatment Methods 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
108010039627 Aprotinin Proteins 0.000 description 6
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
229960004405 aprotinin Drugs 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
230000004069 differentiation Effects 0.000 description 6
229940088598 enzyme Drugs 0.000 description 6
239000000834 fixative Substances 0.000 description 6
239000003102 growth factor Substances 0.000 description 6
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 6
239000007924 injection Substances 0.000 description 6
238000002347 injection Methods 0.000 description 6
238000001000 micrograph Methods 0.000 description 6
102000004169 proteins and genes Human genes 0.000 description 6
108090000623 proteins and genes Proteins 0.000 description 6
230000000717 retained effect Effects 0.000 description 6
238000012360 testing method Methods 0.000 description 6
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 5
102000029816 Collagenase Human genes 0.000 description 5
108060005980 Collagenase Proteins 0.000 description 5
230000010261 cell growth Effects 0.000 description 5
229960002424 collagenase Drugs 0.000 description 5
230000002950 deficient Effects 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
-1 versican Proteins 0.000 description 5
108010073385 Fibrin Proteins 0.000 description 4
102000009123 Fibrin Human genes 0.000 description 4
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
239000005057 Hexamethylene diisocyanate Substances 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
102000016611 Proteoglycans Human genes 0.000 description 4
108010067787 Proteoglycans Proteins 0.000 description 4
241000985282 Symbion Species 0.000 description 4
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
210000004204 blood vessel Anatomy 0.000 description 4
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
238000001493 electron microscopy Methods 0.000 description 4
239000003925 fat Substances 0.000 description 4
229950003499 fibrin Drugs 0.000 description 4
RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 4
230000009545 invasion Effects 0.000 description 4
239000002953 phosphate buffered saline Substances 0.000 description 4
210000003491 skin Anatomy 0.000 description 4
210000000813 small intestine Anatomy 0.000 description 4
159000000000 sodium salts Chemical class 0.000 description 4
239000007787 solid Substances 0.000 description 4
238000001356 surgical procedure Methods 0.000 description 4
RJGYJMFQWGPBGM-UHFFFAOYSA-N 1,2,4-thiadiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCN1 RJGYJMFQWGPBGM-UHFFFAOYSA-N 0.000 description 3
102000016284 Aggrecans Human genes 0.000 description 3
108010067219 Aggrecans Proteins 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
241000287828 Gallus gallus Species 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
102000007547 Laminin Human genes 0.000 description 3
108010085895 Laminin Proteins 0.000 description 3
241001494479 Pecora Species 0.000 description 3
108010025435 Permacol Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
239000003513 alkali Substances 0.000 description 3
239000004599 antimicrobial Substances 0.000 description 3
239000003012 bilayer membrane Substances 0.000 description 3
230000022159 cartilage development Effects 0.000 description 3
230000003833 cell viability Effects 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
235000013330 chicken meat Nutrition 0.000 description 3
229920001577 copolymer Polymers 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
239000012894 fetal calf serum Substances 0.000 description 3
239000000835 fiber Substances 0.000 description 3
210000002950 fibroblast Anatomy 0.000 description 3
230000006870 function Effects 0.000 description 3
239000000417 fungicide Substances 0.000 description 3
239000002874 hemostatic agent Substances 0.000 description 3
210000000629 knee joint Anatomy 0.000 description 3
230000000399 orthopedic effect Effects 0.000 description 3
210000003516 pericardium Anatomy 0.000 description 3
229920000747 poly(lactic acid) Polymers 0.000 description 3
229920001184 polypeptide Polymers 0.000 description 3
235000015277 pork Nutrition 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
238000011160 research Methods 0.000 description 3
IHQKEDIOMGYHEB-UHFFFAOYSA-M sodium dimethylarsinate Chemical compound [Na+].C[As](C)([O-])=O IHQKEDIOMGYHEB-UHFFFAOYSA-M 0.000 description 3
AJKIRUJIDFJUKJ-UHFFFAOYSA-N taurolidine Chemical compound C1NS(=O)(=O)CCN1CN1CNS(=O)(=O)CC1 AJKIRUJIDFJUKJ-UHFFFAOYSA-N 0.000 description 3
229960004267 taurolidine Drugs 0.000 description 3
229950007343 taurultam Drugs 0.000 description 3
238000005406 washing Methods 0.000 description 3
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
229930183010 Amphotericin Natural products 0.000 description 2
QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
229920001287 Chondroitin sulfate Polymers 0.000 description 2
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
229920000045 Dermatan sulfate Polymers 0.000 description 2
102000016359 Fibronectins Human genes 0.000 description 2
108010067306 Fibronectins Proteins 0.000 description 2
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
229930182566 Gentamicin Natural products 0.000 description 2
229920002683 Glycosaminoglycan Polymers 0.000 description 2
229920000288 Keratan sulfate Polymers 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
229920000954 Polyglycolide Polymers 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241000282887 Suidae Species 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
108090000190 Thrombin Proteins 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
230000000735 allogeneic effect Effects 0.000 description 2
229940009444 amphotericin Drugs 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
239000000872 buffer Substances 0.000 description 2
230000003848 cartilage regeneration Effects 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
229940059329 chondroitin sulfate Drugs 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000004132 cross linking Methods 0.000 description 2
238000012258 culturing Methods 0.000 description 2
239000007857 degradation product Substances 0.000 description 2
AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 2
229940051593 dermatan sulfate Drugs 0.000 description 2
229920001971 elastomer Polymers 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
238000000605 extraction Methods 0.000 description 2
239000012530 fluid Substances 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
230000000855 fungicidal effect Effects 0.000 description 2
239000003292 glue Substances 0.000 description 2
229920002674 hyaluronan Polymers 0.000 description 2
229960003160 hyaluronic acid Drugs 0.000 description 2
238000011532 immunohistochemical staining Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000008595 infiltration Effects 0.000 description 2
238000001764 infiltration Methods 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
210000001503 joint Anatomy 0.000 description 2
KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
210000003127 knee Anatomy 0.000 description 2
230000003902 lesion Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
230000033001 locomotion Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
210000004877 mucosa Anatomy 0.000 description 2
230000005305 organ development Effects 0.000 description 2
210000004409 osteocyte Anatomy 0.000 description 2
239000002504 physiological saline solution Substances 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
239000004626 polylactic acid Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000001172 regenerating effect Effects 0.000 description 2
OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 2
239000000565 sealant Substances 0.000 description 2
239000002689 soil Substances 0.000 description 2
238000007711 solidification Methods 0.000 description 2
230000008023 solidification Effects 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
108010070228 surgisis Proteins 0.000 description 2
229920002994 synthetic fiber Polymers 0.000 description 2
229960004072 thrombin Drugs 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
ZEPAXLPHESYSJU-UHFFFAOYSA-N 2,3,4,5,6,7,8-heptahydroxyoctanal Chemical compound OCC(O)C(O)C(O)C(O)C(O)C(O)C=O ZEPAXLPHESYSJU-UHFFFAOYSA-N 0.000 description 1
BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
206010006784 Burning sensation Diseases 0.000 description 1
229930186147 Cephalosporin Natural products 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
102000030746 Collagen Type X Human genes 0.000 description 1
108010022510 Collagen Type X Proteins 0.000 description 1
108010066259 Collagraft Proteins 0.000 description 1
MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
241000557626 Corvus corax Species 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 1
WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
206010056474 Erythrosis Diseases 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N Glycolaldehyde Chemical compound OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
206010019909 Hernia Diseases 0.000 description 1
206010020880 Hypertrophy Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
208000012659 Joint disease Diseases 0.000 description 1
WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
239000002211 L-ascorbic acid Substances 0.000 description 1
235000000069 L-ascorbic acid Nutrition 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000906034 Orthops Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
102000013566 Plasminogen Human genes 0.000 description 1
108010051456 Plasminogen Proteins 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
235000016639 Syzygium aromaticum Nutrition 0.000 description 1
244000223014 Syzygium aromaticum Species 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
238000004026 adhesive bonding Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
208000024429 articular cartilage disease Diseases 0.000 description 1
239000012237 artificial material Substances 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
102000023732 binding proteins Human genes 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
239000012503 blood component Substances 0.000 description 1
239000012267 brine Substances 0.000 description 1
239000000648 calcium alginate Substances 0.000 description 1
235000010410 calcium alginate Nutrition 0.000 description 1
229960002681 calcium alginate Drugs 0.000 description 1
OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 description 1
230000021164 cell adhesion Effects 0.000 description 1
230000036978 cell physiology Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
229940124587 cephalosporin Drugs 0.000 description 1
150000001780 cephalosporins Chemical class 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
239000002131 composite material Substances 0.000 description 1
239000013068 control sample Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229960004544 cortisone Drugs 0.000 description 1
238000012364 cultivation method Methods 0.000 description 1
238000010908 decantation Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000001934 delay Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000005553 drilling Methods 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000035194 endochondral ossification Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
239000004744 fabric Substances 0.000 description 1
125000005313 fatty acid group Chemical group 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
229940126864 fibroblast growth factor Drugs 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
230000004927 fusion Effects 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
239000000499 gel Substances 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
239000008103 glucose Substances 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
229940109738 hematin Drugs 0.000 description 1
150000002402 hexoses Chemical class 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
150000002454 idoses Chemical class 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
229910017053 inorganic salt Inorganic materials 0.000 description 1
210000004347 intestinal mucosa Anatomy 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
238000013150 knee replacement Methods 0.000 description 1
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
230000007774 longterm Effects 0.000 description 1
230000001926 lymphatic effect Effects 0.000 description 1
210000001365 lymphatic vessel Anatomy 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
238000002156 mixing Methods 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
230000004660 morphological change Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
239000011368 organic material Substances 0.000 description 1
201000008482 osteoarthritis Diseases 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
108010003992 parietex Proteins 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
150000002972 pentoses Chemical class 0.000 description 1
229940053363 periguard Drugs 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
239000011505 plaster Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920001610 polycaprolactone Polymers 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
239000005056 polyisocyanate Substances 0.000 description 1
229920001228 polyisocyanate Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
239000002994 raw material Substances 0.000 description 1
230000000250 revascularization Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
239000000523 sample Substances 0.000 description 1
238000009958 sewing Methods 0.000 description 1
239000002356 single layer Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
210000005065 subchondral bone plate Anatomy 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
229940124530 sulfonamide Drugs 0.000 description 1
150000003456 sulfonamides Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
238000004114 suspension culture Methods 0.000 description 1
230000008961 swelling Effects 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
210000004876 tela submucosa Anatomy 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
229940040944 tetracyclines Drugs 0.000 description 1
150000003538 tetroses Chemical class 0.000 description 1
238000010257 thawing Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
210000001694 thigh bone Anatomy 0.000 description 1
210000002303 tibia Anatomy 0.000 description 1
239000003106 tissue adhesive Substances 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
150000003641 trioses Chemical class 0.000 description 1
230000006444 vascular growth Effects 0.000 description 1
230000009790 vascular invasion Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000005303 weighing Methods 0.000 description 1
238000009736 wetting Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3654—Cartilage, e.g. meniscus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Cell Biology (AREA)
Medicinal Chemistry (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Botany (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Physical Education & Sports Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SK1389-2003A 2001-04-12 2002-04-12 Spôsob autológnej transplantácie SK13892003A3 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28325301P	2001-04-12	2001-04-12
PCT/US2002/011497 WO2002083878A1 (en)	2001-04-12	2002-04-12	Method for autologous transplantation

Publications (1)

Publication Number	Publication Date
SK13892003A3 true SK13892003A3 (sk)	2004-07-07

Family

ID=23085209

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1389-2003A SK13892003A3 (sk)	2001-04-12	2002-04-12	Spôsob autológnej transplantácie

Country Status (14)

Country	Link
EP (1)	EP1390471A4 (cs)
JP (1)	JP2005502390A (cs)
CN (1)	CN1514877A (cs)
BR (1)	BR0208879A (cs)
CA (1)	CA2444004A1 (cs)
CZ (1)	CZ20033051A3 (cs)
HU (1)	HUP0401450A3 (cs)
IL (1)	IL158371A0 (cs)
MX (1)	MXPA03009312A (cs)
NO (1)	NO20034581L (cs)
PL (1)	PL367295A1 (cs)
RU (1)	RU2003132877A (cs)
SK (1)	SK13892003A3 (cs)
WO (1)	WO2002083878A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050209705A1 (en) *	2004-03-09	2005-09-22	Niederauer Gabriele G	Implant scaffold combined with autologous or allogenic tissue
US20060100138A1 (en) *	2004-11-10	2006-05-11	Olsen David R	Implantable collagen compositions
DE102005030614B4 (de)	2005-06-30	2014-05-08	Biotissue Ag	Zellfreies Transplantat, dessen Verwendung, Verfahren zu dessen Herstellung, dabei hergestellte Matrix mit Gel und Verfahren zur Herstellung dieser Matrix mit Gel
PL1937293T3 (pl)	2005-09-02	2014-03-31	Ed Geistlich Soehne Ag Fuer Chemische Ind	Sposób naprawy rozdarć łąkotki
EP2698173A1 (en)	2008-02-29	2014-02-19	Coloplast A/S	Compositions and methods for augmentation and regeneration of living tissue in a subject
WO2009106642A1 (en) *	2008-02-29	2009-09-03	Coloplast A/S	Biosynthetic cartilaginous matrix and methods for their production
AU2013290152B2 (en) *	2012-07-11	2016-11-03	Osiris Therapeutics, Inc.	Porated cartilage products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5788625A (en) *	1996-04-05	1998-08-04	Depuy Orthopaedics, Inc.	Method of making reconstructive SIS structure for cartilaginous elements in situ
US5759190A (en) *	1996-08-30	1998-06-02	Vts Holdings Limited	Method and kit for autologous transplantation
US6171340B1 (en) *	1998-02-27	2001-01-09	Mcdowell Charles L.	Method and device for regenerating cartilage in articulating joints

2002
- 2002-04-12 CN CNA02811745XA patent/CN1514877A/zh active Pending
- 2002-04-12 MX MXPA03009312A patent/MXPA03009312A/es not_active Application Discontinuation
- 2002-04-12 EP EP02726736A patent/EP1390471A4/en not_active Withdrawn
- 2002-04-12 BR BR0208879-7A patent/BR0208879A/pt not_active IP Right Cessation
- 2002-04-12 RU RU2003132877/15A patent/RU2003132877A/ru not_active Application Discontinuation
- 2002-04-12 SK SK1389-2003A patent/SK13892003A3/sk unknown
- 2002-04-12 JP JP2002582217A patent/JP2005502390A/ja active Pending
- 2002-04-12 CZ CZ20033051A patent/CZ20033051A3/cs unknown
- 2002-04-12 IL IL15837102A patent/IL158371A0/xx unknown
- 2002-04-12 PL PL02367295A patent/PL367295A1/xx not_active Application Discontinuation
- 2002-04-12 CA CA002444004A patent/CA2444004A1/en not_active Abandoned
- 2002-04-12 HU HU0401450A patent/HUP0401450A3/hu unknown
- 2002-04-12 WO PCT/US2002/011497 patent/WO2002083878A1/en not_active Ceased
2003
- 2003-10-10 NO NO20034581A patent/NO20034581L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ20033051A3 (en)	2004-05-12
JP2005502390A (ja)	2005-01-27
NO20034581D0 (no)	2003-10-10
NO20034581L (no)	2003-12-09
WO2002083878A1 (en)	2002-10-24
EP1390471A4 (en)	2005-04-13
HUP0401450A2 (hu)	2004-11-29
CA2444004A1 (en)	2002-10-24
HUP0401450A3 (en)	2006-11-28
BR0208879A (pt)	2004-06-29
RU2003132877A (ru)	2005-03-10
PL367295A1 (en)	2005-02-21
MXPA03009312A (es)	2004-03-10
IL158371A0 (en)	2004-05-12
CN1514877A (zh)	2004-07-21
EP1390471A1 (en)	2004-02-25

Publication	Publication Date	Title
US20020173806A1 (en)	2002-11-21	Method for autologous transplantation
US7137989B2 (en)	2006-11-21	Method, instruments, and kit for autologous transplantation
EP1006950B1 (en)	2004-04-07	Kit for chondrocytes transplantation in a joint
JP4846233B2 (ja)	2011-12-28	生組織修復インプラント及びその使用方法
AU2002334852A1 (en)	2003-06-26	Method, instruments, and kit for autologous transplantation
SK13892003A3 (sk)	2004-07-07	Spôsob autológnej transplantácie
US20060025786A1 (en)	2006-02-02	Method for autologous transplantation
AU2002257148A1 (en)	2002-10-28	Method for autologous transplantation
HK1064021B (en)	2011-08-26	Instruments for autologous transplantation
HK1069969A (en)	2005-06-10	Method, instruments and kit for autologous transplantation
AU2007234527A1 (en)	2007-12-06	Method, instruments and kit for autologous transplantation